MeiraGTx Holdings (MGTX) EBT Growth (3y) (2020 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 32.79% |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 47.54% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -49.71% |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 12.01% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | 20.92% |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -1.05% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 48.67% |
| 10 | MeiraGTx Holdings | 856.58 Mn | 790.65 Mn | 74.89 Mn | 36.52% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 36.52% |
| Sep 30, 2025 | -26.10% |
| Jun 30, 2025 | -25.83% |
| Mar 31, 2025 | -14.89% |
| Dec 31, 2024 | -63.25% |
| Sep 30, 2024 | -23.19% |
| Jun 30, 2024 | -33.17% |
| Mar 31, 2024 | -30.52% |
| Dec 31, 2023 | -52.63% |
| Sep 30, 2023 | -76.92% |
| Jun 30, 2023 | -7.40% |
| Mar 31, 2023 | -31.94% |
| Dec 31, 2022 | -105.00% |
| Sep 30, 2022 | -31.24% |
| Jun 30, 2022 | -4.40% |
| Mar 31, 2022 | -11.63% |
| Dec 31, 2021 | 28.76% |
| Sep 30, 2021 | -13.54% |
| Jun 30, 2021 | 11.95% |
| Mar 31, 2021 | -6.82% |
| Dec 31, 2020 | -40.14% |
| Sep 30, 2020 | 10.03% |
| Jun 30, 2020 | -49.36% |